The European Commission (EC) has adopted its pharmaceutical strategy for Europe. The announcement follows a period of consultation earlier this year and meets the EC’s goal of finalizing the strategy ...
Last year, pharmaceutical companies spent over $8.1 billion on marketing campaigns, allocating over half of that to reach healthcare providers (HCPs). As the digital era retains its post-pandemic grip ...
Tariff-driven reshoring and trade volatility are forcing network redesign, with disproportionate shortage risk for generics; ...
As federal and state governing bodies intensify scrutiny around direct-to-consumer (DTC) healthcare advertising, brands face a pivotal moment — one that calls not just for compliance, but strategic ...
The biggest untapped resource in the health sector is not a new drug or AI-driven breakthrough—it's the patient’s voice. For decades, the pharmaceutical industry has revolved around science, ...
Understanding enhanced regulatory science and strategy and translating new discoveries into real-world products can make an enormous difference for individual and population health. However, doing so ...
LONDON--(BUSINESS WIRE)--As coronavirus continues to wreak havoc across industries, Quantzig’s sales analytics experts analyze the recent challenges in the pharmaceutical industry and explain why a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results